
  
    
      
        Background_NNP
        Chemokines_NNP are_VBP a_DT large_JJ superfamily_RB of_IN small_JJ ,_,
        structurally-related_JJ peptides_NNS originally_RB discovered_VBN as_IN
        neutrophil_NN attractants_NNS ._. Interleukin-_NNP 8_CD (_( IL-_NNP 8_CD )_) is_VBZ a_DT potent_JJ
        member_NN of_IN the_DT supergene_NN family_NN of_IN CXC_NNP chemokines_NNS with_IN ELR_NNP
        motif_NN (_( ELR_NNP +_NN )_) ._. ELR_NNP +_NN CXC_NNP chemokines_NNS are_VBP potent_JJ angiogenic_JJ
        factors_NNS ,_, whereas_IN ELR_NNP -_: CXC_NNP chemokines_NNS are_VBP potent_JJ angiostatic_JJ
        factors_NNS ._. Studies_NNS have_VBP shown_VBN that_IN these_DT angiogenesis-related_JJ
        activities_NNS are_VBP correlated_JJ with_IN tumorigenesis_NNS in_IN many_JJ tumor_NN
        types_NNS and_CC are_VBP distinct_JJ from_IN their_PRP$ ability_NN to_TO recruit_VB
        neutrophils_NNS [_NN 1_CD 2_CD ]_NN ._.
        Interleukin-_NNP 8_CD (_( IL-_NNP 8_CD )_) is_VBZ inducible_JJ in_IN a_DT wide_JJ range_NN of_IN
        cells_NNS including_VBG lymphocytes_NNS ,_, monocytes_NNS ,_, endothelial_NN cells_NNS ,_,
        fibroblasts_NNS ,_, hepatocytes_NNS ,_, and_CC keratinocytes_NNS [_NN 3_CD 4_CD 5_CD ]_NN ._.
        IL-_NNP 8_CD is_VBZ also_RB found_VBN to_TO be_VB constitutively_RB expressed_VBN in_IN
        several_JJ tumor_NN tissues_NNS including_VBG bronchogenic_JJ carcinoma_NN ,_,
        non-small_JJ cell_NN lung_NN cancer_NN ,_, colorectal_NN carcinoma_NN ,_, breast_NN
        cancer_NN ,_, melanoma_NN ,_, prostate_NN cancer_NN ,_, gastric_JJ carcinoma_NN ,_, and_CC
        ovarian_NN cancer_NN ._. While_IN IL-_NNP 8_CD has_VBZ been_VBN implicated_VBN in_IN
        growth-potentiation_JJ [_NN 6_CD ]_NN ,_, angiogenesis_NNS [_NN 7_CD ]_NN ,_, metastasis_NNS
        [_NN 3_CD 8_CD ]_NN ,_, and_CC tumorigenesis_NNS [_NN 3_CD 6_CD ]_NN of_IN various_JJ tumors_NNS ,_, its_PRP$
        specific_JJ role_NN remains_VBZ unclear_JJ ._. Several_JJ observations_NNS support_VBP
        the_DT assertion_NN that_IN a_DT complex_JJ interaction_NN between_IN IL-_NNP 8_CD and_CC
        several_JJ other_JJ growth_NN factors_NNS ,_, cytokines_NNS ,_, or_CC other_JJ proteins_NNS
        is_VBZ responsible_JJ for_IN these_DT tumor-related_JJ events_NNS [_NN 5_CD 9_CD 10_CD 11_CD
        12_CD 13_CD ]_NN ._. Growth_NN regulated_VBN protein_NN alpha_NN (_( GRO-α_NNP )_) ,_, beta_NN
        (_( GRO-β_NNP )_) ,_, and_CC ENA-_NNP 78_CD have_VBP been_VBN reported_VBN to_TO be_VB co-induced_JJ
        with_IN IL-_NNP 8_CD in_IN A_DT 549_CD cells_NNS stimulated_VBN with_IN two_CD proinflammatory_NN
        cytokines_NNS ,_, IL-_NNP 1_CD β_NN and_CC TNF-α_NNP [_NN 14_CD ]_NN ._. This_DT result_NN is_VBZ
        consistent_JJ with_IN the_DT presence_NN of_IN nuclear_JJ factor_NN kappa_NN B_NNP
        (_( NF-κB_NNP )_) consensus_NN binding_JJ sites_NNS in_IN the_DT promoter_NN regions_NNS of_IN
        all_DT three_CD genes_NNS [_NN 4_CD 15_CD ]_NN ._. In_IN addition_NN ,_, GRO-α_NNP and_CC -_: β_NN are_VBP
        also_RB members_NNS of_IN the_DT ELR_NNP +_NN CXC_NNP cytokine_NN family_NN that_WDT are_VBP
        reported_VBN to_TO be_VB important_JJ mediators_NNS of_IN tumorigenesis_NNS through_IN
        their_PRP$ angiogenic_JJ properties_NNS [_NN 2_CD 16_CD ]_NN ._. They_PRP both_DT share_NN one_CD
        of_IN the_DT IL-_NNP 8_CD receptors_NNS ,_, CXCR_NNP 2_CD ,_, which_WDT has_VBZ been_VBN postulated_JJ to_TO
        regulate_VB the_DT ELR_NNP +_NN CXC_NNP chemokine-mediated_JJ angiogenesis_NNS and_CC
        resulting-tumorigenesis_JJ [_NN 1_CD ]_NN ._. These_DT observations_NNS suggest_VBP
        that_IN GRO-α_NNP and_CC -_: β_NN may_MD exhibit_VB expression_NN profiles_NNS similar_JJ
        to_TO IL-_NNP 8_CD ._. Coordinated_NNP expression_NN of_IN these_DT and_CC other_JJ factors_NNS
        with_IN IL-_NNP 8_CD in_IN certain_JJ tumor_NN tissues_NNS suggests_VBZ that_IN they_PRP may_MD
        be_VB functionally_RB associated_VBN with_IN IL-_NNP 8_CD in_IN these_DT tumors_NNS ._. In_IN
        order_NN to_TO fully_RB understand_VB IL-_NNP 8_CD 's_POS role_NN in_IN these_DT events_NNS ,_, it_PRP
        is_VBZ important_JJ to_TO investigate_VB these_DT coordinately_RB expressed_VBN
        genes_NNS ._. A_DT systematic_JJ ,_, unbiased_JJ approach_NN to_TO identification_NN
        and_CC ranking_NN of_IN proteins_NNS related_VBN to_TO IL-_NNP 8_CD 's_POS expression_NN in_IN
        tumor_NN tissues_NNS /_NN cells_NNS may_MD help_VB to_TO define_VB the_DT scope_NN of_IN IL-_NNP 8_CD 's_POS
        role_NN in_IN tumorigenicity_NN and_CC important_JJ related_VBN interactions_NNS
        with_IN other_JJ factors_NNS ._.
        There_RB are_VBP over_IN 3_CD million_CD human_JJ Expressed_NNP Sequence_NNP Tag_NNP
        (_( EST_NNP )_) records_NNS in_IN GenBank_NNP (_( Table_NNP 1_LS )_) ,_, which_WDT is_VBZ still_RB growing_VBG
        rapidly_RB ._. EST_NN sequences_NNS in_IN GenBank_NNP are_VBP derived_VBN from_IN cDNA_NN
        libraries_NNS generated_VBN from_IN a_DT vast_JJ array_NN of_IN tissue_NN types_NNS
        including_VBG normal_JJ ,_, disease-state_JJ ,_, and_CC variously_RB treated_VBN
        tissues_NNS ._. The_DT number_NN of_IN EST_NNP clones_NNS is_VBZ reported_VBN to_TO be_VB
        proportional_JJ to_TO the_DT abundance_NN of_IN cognate_NN transcripts_NNS in_IN the_DT
        tissue_NN or_CC cell_NN type_NN used_VBN to_TO make_VB the_DT cDNA_NN library_NN and_CC thus_RB
        the_DT EST_NNP distribution_NN can_MD provide_VB a_DT quantitative_JJ assessment_NN
        of_IN differential_NN expression_NN of_IN a_DT gene_NN [_NN 17_CD ]_NN ._. The_DT expanding_VBG
        tissue_NN diversity_NN and_CC EST_NNP coverage_NN have_VBP increased_VBN the_DT
        statistical_JJ power_NN of_IN EST-distribution_NNP based_VBD expression_NN
        analysis_NN ._. An_DT approach_NN using_VBG EST_NNP expression_NN data_NNS as_IN a_DT binary_JJ
        variable_JJ (_( present_JJ or_CC absent_JJ in_IN a_DT cDNA_NN library_NN )_) has_VBZ
        previously_RB identified_VBN prostate_NN cancer-associated_JJ genes_NNS [_NN 18_CD
        ]_NN ._. We_PRP are_VBP reporting_VBG here_RB a_DT novel_NN 
        in_IN silico_NN approach_NN for_IN identification_NN
        of_IN genes_NNS whose_WP$ mRNA_NN are_VBP enriched_JJ in_IN libraries_NNS where_WRB IL-_NNP 8_CD is_VBZ
        represented_VBN ._. We_PRP focused_VBD on_IN ESTs_NNP from_IN cDNA_NN libraries_NNS in_IN
        which_WDT IL-_NNP 8_CD has_VBZ been_VBN sequenced_JJ at_IN least_JJS once_RB and_CC analyzed_VBD
        the_DT EST_NNP frequency_NN of_IN occurrence_NN for_IN all_DT other_JJ genes_NNS in_IN
        these_DT IL-_NNP 8_CD related_VBN cDNA_NN libraries_NNS ._. Those_DT cDNA_NN libraries_NNS
        were_VBD further_JJ catalogued_JJ into_IN tumor_NN and_CC non-tumor_JJ libraries_NNS ,_,
        which_WDT allowed_VBD us_PRP to_TO identify_VB genes_NNS whose_WP$ expression_NN profile_NN
        is_VBZ closely_RB related_VBN to_TO that_DT of_IN IL-_NNP 8_CD in_IN tumor_NN tissues_NNS ._.
        Additional_JJ File_NNP 1_CD
        IL-_NNP 8_CD cDNA_NN Libraries_NNP List_NN of_IN all_DT cDNA_NN libraries_NNS in_IN which_WDT
        IL-_NNP 8_CD has_VBZ been_VBN sequenced_JJ at_IN least_JJS once_RB ._.
        Click_NNP here_RB for_IN file_NN
      
      
        Results_NNS
        
          Genes_NNP co-expressed_JJ with_IN IL-_NNP 8_CD
          We_PRP found_VBD that_IN IL-_NNP 8_CD has_VBZ been_VBN sequenced_JJ in_IN 53_CD dbEST_NN cDNA_NN
          libraries_NNS (_( Table_NNP 1_CD and_CC Additional_JJ file_NN 1_LS )_) ._. Using_VBG these_DT
          cDNA_NN libraries_NNS (_( referred_VBD to_TO as_IN IL-_NNP 8_CD tissue_NN )_) ,_, we_PRP generated_VBD
          a_DT reference_NN database_NN for_IN all_PDT the_DT genes_NNS and_CC their_PRP$
          expression_NN profile_NN relationship_NN (_( measure_NN by_IN Z-_NNP score_NN )_) with_IN
          IL-_NNP 8_CD ._. The_DT complete_JJ list_NN of_IN genes_NNS is_VBZ provided_VBN in_IN
          additional_JJ file_NN 2_CD ,_, along_IN with_IN a_DT distribution_NN table_NN based_VBN
          on_IN contig_NN size_NN and_CC Z-_NNP score_NN (_( Table_NNP 2_LS )_) ._. A_DT gene_NN could_MD be_VB
          represented_VBN by_IN multiple_JJ contigs_NNS which_WDT represent_VBP splice_NN
          variants_NNS and_CC sequencing_VBG errors_NNS ._. In_IN this_DT database_NN ,_, we_PRP
          provide_VBP the_DT statistics_NNS for_IN each_DT contig_NN ,_, including_VBG the_DT
          number_NN of_IN EST_NNP clones_NNS ,_, cDNA_NN libraries_NNS ,_, EST_NNP clones_NNS in_IN IL-_NNP 8_CD
          tissue_NN ,_, and_CC cDNA_NN libraries_NNS in_IN IL-_NNP 8_CD tissue_NN ._. First_LS we_PRP
          evaluated_VBD the_DT performance_NN of_IN this_DT search_NN using_VBG the_DT
          distribution_NN analysis_NN results_NNS for_IN some_DT known_VBN genes_NNS (_( Table_NNP
          3_LS )_) ._. The_DT co-expression_JJ of_IN IL-_NNP 8_CD with_IN IL-_NNP 6_CD ,_, GRO-α_NNP ,_, and_CC GRO-β_NNP
          in_IN many_JJ tissues_NNS has_VBZ been_VBN well_RB documented_VBN [_NN 5_CD 14_CD 19_CD ]_NN ,_,
          and_CC those_DT genes_NNS are_VBP identified_VBN here_RB as_IN IL-_NNP 8_CD related_VBN genes_NNS
          with_IN an_DT IL-_NNP 8_CD Z-_NNP score_NN >_NN =_SYM 3_CD ._. The_DT GRO-γ_NNP and_CC ENA-_NNP 78_CD [_NN 14_CD ]_NN
          also_RB show_NN a_DT high_JJ IL-_NNP 8_CD Z-_NNP score_NN ,_, although_IN the_DT available_JJ EST_NNP
          clone_NN number_NN for_IN these_DT two_CD genes_NNS is_VBZ much_RB smaller_JJR ._.
          Successful_JJ identification_NN of_IN these_DT genes_NNS demonstrates_VBZ the_DT
          value_NN of_IN our_PRP$ 
          in_IN silico_NN approach_NN ._. Besides_IN
          Z-_NNP score_NN ,_, this_DT database_NN can_MD be_VB sorted_VBN in_IN many_JJ different_JJ
          ways_NNS ._. For_IN example_NN ,_, we_PRP can_MD adjust_VB the_DT stringency_NN of_IN
          correlation_NN by_IN using_VBG the_DT number_NN of_IN IL-_NNP 8_CD cDNA_NN libraries_NNS as_IN
          a_DT cutoff_NN parameter_NN ._.
          Additional_JJ File_NNP 2_CD
          Contigs_NNP identified_VBD in_IN IL_NNP 8_CD tissue_NN List_NN of_IN contigs_NNS that_WDT
          have_VBP at_IN least_JJS one_CD EST_NNP in_IN IL_NNP 8_CD tissue_NN ._.
          Click_NNP here_RB for_IN file_NN
          Additional_JJ File_NNP 3_CD
          Contigs_NNP identified_VBD in_IN IL_NNP 8_CD -_: tumor_NN tissue_NN List_NN of_IN contigs_NNS
          that_WDT have_VBP at_IN least_JJS one_CD EST_NNP in_IN IL_NNP 8_CD -_: tumor_NN tissue_NN
          Click_NNP here_RB for_IN file_NN
          The_DT significance_NN of_IN this_DT study_NN lies_VBZ in_IN the_DT generation_NN
          of_IN a_DT complete_JJ reference_NN database_NN for_IN IL-_NNP 8_CD co-expressed_JJ
          genes_NNS ._. We_PRP present_JJ here_RB a_DT list_NN of_IN 36_CD genes_NNS with_IN high_JJ EST_NNP
          clone_NN count_NN (_( >_NN =_SYM 100_CD )_) and_CC high_JJ Z-_NNP score_NN (_( >_NN =_SYM 3_LS )_)
          (_( referred_VBD to_TO as_IN IL-_NNP 8_CD genes_NNS ,_, I-_NNP 1_CD ,_, I-_NNP 2_CD ,_, ._. ._. ._. ,_, I-_NNP 36_CD )_) (_( Table_NNP
          4_LS )_) to_TO illustrate_VB the_DT usage_NN of_IN this_DT reference_NN database_NN ._. A_DT
          high_JJ EST_NNP clone_NN count_NN is_VBZ used_VBN to_TO ensure_VB the_DT statistic_NN
          significance_NN of_IN the_DT data_NNS mining_NN results_NNS ._. IL-_NNP 8_CD tissues_NNS
          represent_VBP both_DT tumor_NN tissues_NNS /_NN cells_NNS (_( IL-_NNP 8_CD -_: tumor_NN )_) and_CC
          non-tumor_JJ tissues_NNS /_NN cells_NNS (_( Table_NNP 1_CD and_CC Additional_JJ file_NN 1_LS )_) ._.
          To_TO generate_VB a_DT tumor_NN expression_NN profile_NN ,_, the_DT percentage_NN of_IN
          IL-_NNP 8_CD -_: tumor_NN clones_NNS versus_CC IL-_NNP 8_CD clones_NNS (_( R_NN 
          tumor_NN )_) was_VBD calculated_VBN for_IN the_DT 36_CD IL-_NNP 8_CD
          genes_NNS ._. The_DT resulting_VBG graph_NN is_VBZ shown_VBN in_IN Figure_NN 1_CD ._. The_DT R_NN 
          tumor_NN profile_NN reveals_VBZ a_DT bimodal_NN
          distribution_NN ._. In_IN the_DT case_NN of_IN IL-_NNP 8_CD ,_, tumor_NN clones_NNS account_VBP
          for_IN approximately_RB 17_CD %_NN of_IN all_DT IL-_NNP 8_CD clones_NNS (_( R_NN 
          tumor_NN =_SYM 17_CD %_NN )_) ._. Eleven_CD IL-_NNP 8_CD genes_NNS
          exhibit_NN a_DT R_NN 
          tumor_NN of_IN greater_JJR than_IN 80_CD %_NN ;_: five_CD of_IN
          these_DT being_VBG greater_JJR than_IN 95_CD %_NN (_( kruppel-like_JJ factor_NN 2_CD
          (_( KLF_NNP 2_LS )_) ,_, presenilin_NN 1_CD (_( PS_NNP 1_LS )_) ,_, neural_NN proliferation_NN and_CC
          differentiation_NN control_NN protein-_NN 1_CD (_( NPDC_NNP 1_LS )_) ,_, GW_NNP 112_CD and_CC
          claudin-_NN 3_LS )_) ._. On_IN the_DT other_JJ hand_NN ,_, eight_CD genes_NNS were_VBD not_RB found_VBN
          in_IN any_DT IL-_NNP 8_CD -_: tumor_NN related_VBD library_NN (_( R_NN 
          tumor_NN =_SYM 0_CD )_) ._.
          For_IN comparison_NN with_IN GRO-α_NNP and_CC GRO-β_NNP ,_, the_DT ratios_NNS of_IN
          IL-_NNP 8_CD clones_NNS ,_, GRO-α_NNP clones_NNS and_CC GRO-β_NNP clones_NNS to_TO total_JJ
          clones_NNS (_( R_NN 
          il_NN 8_CD ,_, R_NNP 
          GRO-α_NNP and_CC R_NNP 
          GRO-β_NNP )_) for_IN each_DT IL-_NNP 8_CD gene_NN were_VBD
          analyzed_VBN ._. Approximately_RB half_NN of_IN the_DT IL-_NNP 8_CD genes_NNS show_VBP
          similar_JJ correlation_NN with_IN all_DT three_CD chemokines_NNS ._. As_IN an_DT
          example_NN ,_, GW_NNP 112_CD exhibits_VBZ high_JJ correlation_NN with_IN IL-_NNP 8_CD ,_, GRO-α_NNP
          and_CC -_: β_NN (_( R_NN 
          il_NN 8_CD =_SYM 69_CD %_NN ,_, R_NNP 
          GRO-α_NNP =_SYM 71_CD %_NN ,_, R_NNP 
          GRO-β_NNP =_SYM 68_CD %_NN )_) ._. On_IN the_DT other_JJ hand_NN ,_, KLF_NNP 2_CD
          (_( R_NN 
          il_NN 8_CD =_SYM 71_CD %_NN ,_, R_NNP 
          GRO-α_NNP =_SYM 16_CD %_NN ,_, R_NNP 
          GRO-β_NNP =_SYM 2_CD %_NN )_) and_CC PS_NNP 1_CD (_( R_NN 
          il_NN 8_CD =_SYM 65_CD %_NN ,_, R_NNP 
          GRO-α_NNP =_SYM 5_CD %_NN ,_, R_NNP 
          GRO-β_NNP =_SYM 3_CD %_NN )_) show_NN high_JJ correlation_NN with_IN
          IL-_NNP 8_CD and_CC only_RB slight_JJ association_NN with_IN GRO-α_NNP or_CC GRO-β_NNP ._.
        
        
          Genes_NNP co-expressed_JJ with_IN IL-_NNP 8_CD in_IN tumor_NN tissues_NNS or_CC
          cell_NN lines_NNS
          A_DT set_NN of_IN tumor_NN cDNA_NN libraries_NNS in_IN which_WDT IL-_NNP 8_CD is_VBZ
          expressed_VBN (_( a_DT subset_NN of_IN the_DT IL-_NNP 8_CD tissue_NN cDNA_NN libraries_NNS )_) ,_,
          was_VBD generated_VBN and_CC is_VBZ referred_VBN to_TO as_IN IL-_NNP 8_CD -_: tumor_NN tissue_NN ._.
          This_DT virtual_JJ tissue_NN consists_VBZ of_IN 16_CD cDNA_NN libraries_NNS
          (_( 171_CD ,_, 521_CD cDNA_NN clones_NNS )_) (_( Table_NNP 1_CD and_CC Additional_JJ file_NN 1_LS )_) ._. An_DT
          IL-_NNP 8_CD -_: tumor_NN gene_NN database_NN was_VBD established_VBN based_VBN on_IN these_DT
          libraries_NNS ._. The_DT complete_JJ list_NN of_IN genes_NNS is_VBZ provided_VBN in_IN
          additional_JJ file_NN 3_CD ,_, along_IN with_IN a_DT distribution_NN table_NN based_VBN
          on_IN contig_NN size_NN and_CC Z-_NNP score_NN (_( Table_NNP 2_LS )_) ._. We_PRP present_JJ here_RB 42_CD
          candidate_NN genes_NNS with_IN relatively_RB high_JJ levels_NNS of_IN expression_NN
          in_IN IL-_NNP 8_CD -_: tumor_NN tissue_NN (_( EST_NNP clone_NN count_NN >_NN =_SYM 100_CD and_CC
          IL-_NNP 8_CD -_: tumor_NN Z-_NNP score_NN >_NN =_SYM 3_LS )_) (_( referred_VBD to_TO as_IN IL-_NNP 8_CD -_: tumor_NN
          genes_NNS ,_, IT-_NNP 1_CD ,_, IT-_NNP 2_CD ,_, ._. ._. ._. ,_, IT-_NNP 42_CD )_) (_( Table_NNP 5_LS )_) ._. To_TO determine_VB
          whether_IN these_DT genes_NNS are_VBP specifically_RB related_VBN to_TO
          IL-_NNP 8_CD -_: tumor_NN tissue_NN or_CC whether_IN they_PRP are_VBP also_RB commonly_RB found_VBD
          in_IN tumors_NNS lacking_VBG IL-_NNP 8_CD expression_NN ,_, the_DT ratio_NN between_IN
          IL-_NNP 8_CD -_: tumor_NN clones_NNS and_CC general_JJ tumor_NN clones_NNS (_( R_NN 
          il_NN 8_CD tumor_NN )_) was_VBD plotted_VBD for_IN IL-_NNP 8_CD -_: tumor_NN
          genes_NNS (_( Figure_NN 2_LS )_) ._. The_DT R_NN 
          il_NN 8_CD tumor_NN for_IN all_DT IL-_NNP 8_CD tumor_NN genes_NNS are_VBP
          greater_JJR than_IN 38_CD %_NN ,_, which_WDT is_VBZ much_RB higher_JJR than_IN the_DT expected_VBN
          background_NN ratio_NN between_IN IL-_NNP 8_CD -_: tumor_NN clones_NNS (_( 171521_CD ,_, Table_NNP
          1_LS )_) and_CC general_JJ tumor_NN clones_NNS (_( 864428_CD ,_, Table_NNP 1_LS )_) ._. A_DT few_JJ of_IN
          these_DT genes_NNS are_VBP highly_RB specific_JJ to_TO IL-_NNP 8_CD -_: tumor_NN tissues_NNS ._.
          Most_JJS notably_RB GW_NNP 112_CD ,_, PS_NNP 1_CD ,_, and_CC KLF_NNP 2_CD show_NN R_NN 
          il_NN 8_CD tumor_NN values_NNS of_IN 86_CD %_NN ,_, 81_CD %_NN and_CC 76_CD %_NN
          respectively_RB ._.
        
      
      
        Discussion_NNP
        The_DT vast_JJ amount_NN of_IN available_JJ EST_NNP data_NNS allows_VBZ expression_NN
        analysis_NN based_VBN solely_RB on_IN computational_NN methods_NNS ._. It_PRP is_VBZ
        possible_JJ to_TO construct_VB a_DT "_'' virtual_JJ tissue_NN "_'' based_VBN on_IN the_DT
        expression_NN pattern_NN of_IN a_DT particular_JJ gene_NN or_CC group_NN of_IN genes_NNS
        (_( e_SYM ._. g_SYM ._. tumor_NN marker_NN genes_NNS )_) ._. It_PRP is_VBZ also_RB possible_JJ to_TO group_VB
        genes_NNS by_IN tissue_NN type_NN through_IN combining_VBG genes_NNS from_IN the_DT same_JJ
        source_NN tissue_NN (_( e_SYM ._. g_SYM ._. tumor_NN ,_, brain_NN ,_, etc_FW ._. )_) ._. In_IN this_DT study_NN we_PRP
        have_VBP generated_VBN "_'' virtual_JJ tissues_NNS "_'' based_VBN on_IN (_( a_DT )_) expression_NN of_IN
        IL-_NNP 8_CD in_IN all_DT tissues_NNS and_CC (_( b_SYM )_) expression_NN of_IN IL-_NNP 8_CD in_IN tumor_NN
        tissues_NNS ._. Next_JJ we_PRP generated_VBD lists_NNS of_IN genes_NNS that_WDT are_VBP most_RBS
        highly_RB co-expressed_JJ with_IN IL-_NNP 8_CD in_IN these_DT two_CD virtual_JJ tissues_NNS ._.
        Since_IN the_DT method_NN is_VBZ not_RB limited_VBN to_TO genes_NNS previously_RB
        correlated_JJ with_IN IL-_NNP 8_CD expression_NN nor_CC to_TO known_VBN genes_NNS ,_, we_PRP have_VBP
        the_DT opportunity_NN to_TO identify_VB previously_RB overlooked_VBD
        correlations_NNS with_IN known_VBN or_CC novel_NN genes_NNS ._. In_IN addition_NN ,_, the_DT
        relative_JJ strength_NN of_IN the_DT correlations_NNS is_VBZ measured_VBN by_IN a_DT
        Z-_NNP score_NN based_VBN on_IN the_DT number_NN of_IN clones_NNS representing_VBG IL-_NNP 8_CD or_CC
        IL-_NNP 8_CD -_: tumor_NN tissue_NN compared_VBN with_IN the_DT total_JJ number_NN of_IN clones_NNS ._.
        Assuming_VBG that_IN co-expression_JJ is_VBZ related_VBN to_TO function_VB ,_, these_DT
        Z-_NNP scores_NNS provide_VBP a_DT basis_NN for_IN ranking_JJ genes_NNS according_VBG to_TO
        potential_JJ involvement_NN in_IN IL-_NNP 8_CD 's_POS function_NN ._. This_DT reference_NN
        database_NN for_IN genes_NNS co-expressed_JJ with_IN IL-_NNP 8_CD can_MD be_VB
        cross-referenced_JJ with_IN other_JJ large_JJ scale_NN expression_NN
        analyses_NNS ,_, such_JJ as_IN microarray_NN experiments_NNS ,_, to_TO help_VB decipher_NN
        the_DT regulation_NN network_NN and_CC the_DT functions_NNS of_IN IL-_NNP 8_CD and_CC IL-_NNP 8_CD
        co-expressed_JJ genes_NNS ._.
        Among_IN the_DT genes_NNS most_RBS highly_RB correlated_JJ with_IN IL-_NNP 8_CD in_IN
        tumor_NN tissues_NNS are_VBP KLF_NNP 2_CD ,_, PS_NNP 1_CD ,_, VEGF_NNP ,_, and_CC tumor_NN necrosis_NNS
        factor_NN receptor-_NN 1_CD (_( TNFR-_NNP 1_LS )_) ,_, lumican_NN (_( keratin_NN sulfate_NN
        proteoglycan_NN )_) ,_, claudin-_NN 3_CD ,_, and_CC perlecan_NN ._. Cytokines_NNP (_( IL-_NNP 2_CD and_CC
        IL-_NNP 7_CD )_) induce_VB the_DT expression_NN of_IN KLF_NNP 2_CD in_IN activated_VBN T_NN cells_NNS
        which_WDT correlates_NNS with_IN their_PRP$ survival_NN [_NN 20_CD ]_NN ._. They_PRP suggest_VBP
        that_IN KLF_NNP 2_CD may_MD be_VB involved_VBN in_IN avoiding_VBG activation-induced_JJ
        cell_NN death_NN ._. It_PRP is_VBZ possible_JJ that_IN IL-_NNP 8_CD may_MD also_RB mediate_VB
        similar_JJ actions_NNS ._. This_DT type_NN of_IN action_NN could_MD increase_VB the_DT
        ability_NN of_IN tumor_NN cells_NNS to_TO survive_VB under_IN conditions_NNS where_WRB
        cells_NNS normally_RB apoptose_NN ._.
        Lumican_NNP expression_NN has_VBZ previously_RB been_VBN correlated_JJ with_IN
        higher_JJR tumor_NN grade_NN ,_, lower_JJR estrogen_NN levels_NNS in_IN the_DT tumor_NN and_CC
        younger_JJR age_NN of_IN patients_NNS in_IN human_JJ breast_NN cancer_NN [_NN 21_CD ]_NN ._. In_IN
        addition_NN ,_, lumican_NN is_VBZ structurally_RB related_VBN to_TO both_DT biglycan_NN
        which_WDT is_VBZ among_IN the_DT top_JJ IL-_NNP 8_CD -_: tumor_NN related_VBD genes_NNS and_CC the_DT
        human_JJ embryonal_NN carcinoma_NN marker_NN antigen_NN TRA-_NNP 1_CD -_: 60_CD [_NN 22_CD ]_NN ._.
        These_DT relationships_NNS support_VBP the_DT hypothesis_NNS that_WDT lumican_NN may_MD
        be_VB a_DT tumor_NN related_VBD protein_NN involved_VBN with_IN IL-_NNP 8_CD 's_POS tumorigenic_JJ
        function_NN ._.
        PS_NNP 1_CD was_VBD also_RB found_VBN to_TO be_VB highly_RB correlated_JJ with_IN IL-_NNP 8_CD in_IN
        both_DT the_DT entire_JJ list_NN of_IN tissues_NNS and_CC specifically_RB in_IN tumor_NN
        tissues_NNS ._. Based_VBN on_IN EST_NNP distribution_NN ,_, presenilin_NN 2_CD (_( PS_NNP 2_LS )_) is_VBZ
        less_RBR related_JJ to_TO IL-_NNP 8_CD -_: tumor_NN libraries_NNS (_( Z-_NNP score_NN =_SYM 0_CD ._. 3_CD ,_,
        IL-_NNP 8_CD -_: tumor_NN clone_NN /_NN Total_NNP Clone_NNP =_SYM 10_CD %_NN )_) ._. In_IN the_DT breast_NN tumor_NN
        microarray_NN experiments_NNS ,_, unlike_IN PS_NNP 1_CD ,_, the_DT peak_NN level_NN of_IN
        expression_NN for_IN PS_NNP 2_CD is_VBZ not_RB in_IN BT-_NNP 549_CD ._. PS_NNP 1_CD is_VBZ a_DT gene_NN involved_VBN
        in_IN early-onset_JJ familial_NN Alzheimer_NNP 's_POS disease_NN ._. There_EX is_VBZ
        accumulating_VBG evidence_NN that_IN mutations_NNS in_IN PS_NNP 1_CD accelerate_VB
        neurodegeneration_NN and_CC facilitate_VB apoptosis_NNS ,_, and_CC some_DT
        researchers_NNS [_NN 23_CD ]_NN suggest_VBP an_DT association_NN with_IN the_DT p_NN 53_CD
        signal_NN transduction_NN pathway_NN ._. It_PRP was_VBD suggested_VBN that_IN
        down-regulation_JJ of_IN PS_NNP 1_CD by_IN wildtype_NN p_NN 53_CD and_CC also_RB p_NN 21_CD
        WAF-_NNP 1_CD may_MD be_VB independent_JJ mechanisms_NNS leading_VBG to_TO apoptosis_NNS and_CC
        tumor_NN suppression_NN [_NN 24_CD ]_NN ._. Our_PRP$ data_NNS correlating_VBG PS_NNP 1_CD with_IN
        IL-_NNP 8_CD -_: tumor_NN related_VBD tissue_NN also_RB suggest_VBP a_DT potential_JJ
        anti-apoptotic_JJ role_NN for_IN PS_NNP 1_CD in_IN tumorigenesis_NNS ._.
        Vascular_NNP endothelial_NN growth_NN factor_NN (_( VEGF_NNP )_) ,_, like_IN IL-_NNP 8_CD ,_, is_VBZ
        a_DT potent_JJ mediator_NN of_IN angiogenesis_NNS ._. VEGF_NNP has_VBZ been_VBN shown_VBN to_TO
        regulate_VB angiogenesis_NNS and_CC metastasis_NNS of_IN bladder_NN cancer_NN [_NN 25_CD
        ]_NN and_CC several_JJ recent_JJ studies_NNS have_VBP reported_VBN correlations_NNS
        with_IN IL-_NNP 8_CD in_IN several_JJ cell_NN types_NNS including_VBG bladder_NN cancer_NN
        (_( TCC_NNP )_) ,_, non-small_JJ cell_NN lung_NN cancer_NN (_( NSCLC_NNP )_) [_NN 26_CD 27_CD ]_NN ,_, human_JJ
        brain_NN microvascular_NN endothelial_NN cells_NNS (_( HBMECS_NNP )_) [_NN 28_CD ]_NN and_CC
        monocytes_NNS [_NN 29_CD ]_NN ._. These_DT data_NNS collectively_RB demonstrate_VBP the_DT
        correlation_NN of_IN VEGF_NNP with_IN IL-_NNP 8_CD in_IN tumor_NN tissues_NNS ._.
        TNF-α_NNP is_VBZ a_DT well-characterized_JJ ,_, potent_JJ inducer_NN of_IN IL-_NNP 8_CD
        transcription_NN and_CC an_DT anti-apoptotic_JJ agent_NN [_NN 30_CD 31_CD 32_CD ]_NN ._.
        Roebuck_NNP provides_VBZ a_DT detailed_VBN analysis_NN of_IN IL-_NNP 8_CD promoter_NN
        structure_NN including_VBG a_DT promoter_NN recruitment_NN mechanism_NN which_WDT
        involves_VBZ TNF-α_NNP and_CC the_DT cooperativity_NN of_IN NF-kB_NNP and_CC NF-IL-_NNP 6_CD
        binding_JJ sites_NNS [_NN 4_CD 32_CD ]_NN ._. TNF-α_NNP exerts_NNS many_JJ of_IN its_PRP$ effects_NNS
        through_IN TNFR-_NNP 1_CD and_CC TNFR-_NNP 2_CD receptors_NNS ,_, thus_RB co-expression_JJ of_IN
        these_DT receptors_NNS with_IN IL-_NNP 8_CD might_MD be_VB anticipated_VBN ._. Our_PRP$
        analysis_NN does_VBZ reveal_VB a_DT correlation_NN between_IN TNFR-_NNP 1_CD and_CC IL-_NNP 8_CD
        expression_NN ._. Using_VBG another_DT bioinformatic_JJ approach_NN ,_, Eidelman_NNP
        et_CC al_NN ._. report_NN a_DT close_JJ relationship_NN between_IN IL-_NNP 8_CD secretion_NN
        in_IN cystic_JJ fibrosis_NNS cells_NNS and_CC expression_NN of_IN genes_NNS from_IN the_DT
        TNFR-_NNP 1_CD /_NN NFkB_NNP pathway_NN ._. As_IN is_VBZ the_DT case_NN for_IN several_JJ other_JJ genes_NNS
        found_VBD in_IN this_DT study_NN ,_, the_DT TNFR-_NNP 1_CD /_NN NFkB_NNP pathway_NN is_VBZ associated_VBN
        with_IN p_NN 53_CD /_NN p_NN 21_CD WAF-_NNP 1_CD tumor_NN suppressor_NN systems_NNS [_NN 33_CD 34_CD 35_CD 36_CD 37_CD
        ]_NN ._.
        Our_PRP$ analysis_NN identified_VBD several_JJ interesting_JJ genes_NNS
        co-expressed_JJ with_IN IL-_NNP 8_CD in_IN tumor_NN tissues_NNS which_WDT have_VBP not_RB
        previously_RB been_VBN associated_VBN with_IN IL-_NNP 8_CD ._. Along_IN with_IN lumican_NN ,_,
        claudin-_NN 3_CD ,_, KLF_NNP 2_CD ,_, PS_NNP 1_CD ,_, VEGF_NNP and_CC TNFR-_NNP 1_CD mentioned_VBN above_IN ,_,
        these_DT include_VBP several_JJ secreted_JJ proteins_NNS (_( secreted_JJ apoptosis_NNS
        related_VBD protein_NN 1_CD and_CC NPDC_NNP 1_LS )_) which_WDT are_VBP also_RB likely_JJ to_TO
        function_VB in_IN coordination_NN with_IN IL-_NNP 8_CD ;_: several_JJ genes_NNS from_IN the_DT
        well-known_JJ family_NN of_IN complement_VB factors_NNS (_( C_NNP 1_CD esterase_NN ,_, human_JJ
        complement_VB C_NNP 4_CD A_DT and_CC complement_VB factor_NN B_NNP )_) ;_: and_CC several_JJ
        unknown_JJ or_CC hypothetical_JJ genes_NNS ._. Interestingly_RB ,_, several_JJ of_IN
        the_DT genes_NNS correlate_VBP with_IN the_DT p_NN 53_CD /_NN p_NN 21_CD WAF-_NNP 1_CD tumor_NN suppressor_NN
        network_NN ._. We_PRP expect_VBP that_IN some_DT of_IN these_DT genes_NNS may_MD present_VB
        important_JJ therapeutic_JJ targets_NNS at_IN one_CD or_CC more_JJR levels_NNS in_IN the_DT
        network_NN of_IN IL-_NNP 8_CD mediated_JJ interactions_NNS related_VBN to_TO
        tumorigenesis_NNS ._.
        Like_IN all_DT EST-based_NNP expression_NN analysis_NN ,_, there_EX are_VBP
        limitations_NNS for_IN this_DT 
        in_IN silico_NN method_NN ._. First_LS ,_, EST-based_NNP
        expression_NN analysis_NN is_VBZ not_RB suitable_JJ for_IN transcripts_NNS with_IN
        low_JJ abundance_NN (_( no_DT or_CC few_JJ representative_NN ESTs_NNP in_IN the_DT
        database_NN )_) ,_, which_WDT precludes_VBZ statistical_JJ analysis_NN ._. Second_JJ ,_,
        EST-based_NNP expression_NN analysis_NN can_MD only_RB indicate_VB the_DT
        co-expression_JJ of_IN genes_NNS ,_, but_CC can_MD not_RB accurately_RB measure_VB the_DT
        expression_NN level_NN ._. Third_NNP ,_, to_TO generate_VB a_DT comprehensive_JJ
        reference_NN database_NN ,_, we_PRP decided_VBD not_RB to_TO exclude_VB cDNA_NN
        libraries_NNS based_VBN on_IN the_DT sequence_NN depth_NN or_CC special_JJ
        manipulation_NN (_( e_SYM ._. g_SYM ._. subtraction_NN and_CC normalization_NN )_) ._. The_DT
        depth_NN of_IN sequencing_VBG and_CC special_JJ manipulation_NN are_VBP not_RB
        consistent_JJ across_IN cDNA_NN libraries_NNS ,_, which_WDT could_MD also_RB
        influence_VB the_DT sensitivity_NN of_IN the_DT analysis_NN ._.
        The_DT computational_NN expression_NN analysis_NN methods_NNS developed_VBN
        here_RB are_VBP not_RB limited_VBN to_TO the_DT identification_NN of_IN IL-_NNP 8_CD related_VBN
        genes_NNS ,_, but_CC can_MD also_RB be_VB applied_VBN to_TO many_JJ other_JJ proteins_NNS of_IN
        interest_NN ._. This_DT method_NN is_VBZ complementary_JJ to_TO other_JJ large-scale_JJ
        expression_NN analysis_NN methods_NNS (_( e_SYM ._. g_SYM ._. microarray_NN )_) in_IN that_IN it_PRP is_VBZ
        not_RB limited_VBN by_IN the_DT physical_JJ presence_NN of_IN a_DT gene_NN on_IN
        microarray_NN ,_, thus_RB it_PRP offers_VBZ an_DT unique_JJ approach_NN to_TO
        discovering_VBG potential_JJ functional_JJ links_NNS between_IN genes_NNS
        through_IN expression_NN profiling_VBG ._.
      
      
        Methods_NNP
        
          In_IN silicoexpression_NN analysis_NN
          All_DT non-commercial_JJ software_NN used_VBN in_IN these_DT studies_NNS was_VBD
          written_VBN in_IN PERL_NNP 5_CD ._. 0_CD ._. Human_NNP EST_NNP sequence_NN and_CC cDNA_NN library_NN
          information_NN were_VBD retrieved_VBN from_IN GenBank_NNP (_( Release_NNP 120_CD )_) and_CC
          an_DT in-house_JJ relational_NN database_NN model_NN (_( Sybase_NNP ,_, SQL_NNP Server_NNP
          Release_NNP 11_CD ._. 0_CD ,_, CA_NNP ,_, Sybase_NNP Inc_NNP ._. )_) was_VBD created_VBN to_TO mirror_VB the_DT
          public_JJ human_JJ EST_NNP database_NN (_( dbEST_NN )_) ._. The_DT EST_NNP sequences_NNS were_VBD
          first_JJ binned_JJ into_IN clusters_NNS if_IN they_PRP share_VBP the_DT same_JJ 21_CD mer_NN
          tag_NN beginning_VBG with_IN ATG_NNP or_CC CTG_NNP ._. Next_JJ ,_, ESTs_NNP in_IN each_DT cluster_NN
          were_VBD assembled_VBN into_IN contigs_NNS using_VBG the_DT PHRAP_NNP sequence_NN
          assembly_NN software_NN (_( Phil_NNP Green_NNP ,_, Unpublished_NNP )_) ._. Based_VBN on_IN the_DT
          ESTs_NNP corresponding_JJ to_TO IL-_NNP 8_CD in_IN its_PRP$ cognate_NN contig_NN ,_, we_PRP
          generated_VBD a_DT set_NN of_IN cDNA_NN libraries_NNS in_IN which_WDT IL-_NNP 8_CD is_VBZ
          represented_VBN ._. This_DT set_NN of_IN libraries_NNS is_VBZ referred_VBN to_TO as_IN IL-_NNP 8_CD
          tissue_NN and_CC can_MD be_VB considered_VBN as_IN a_DT virtual_JJ tissue_NN
          consisting_VBG of_IN 53_CD cDNA_NN libraries_NNS (_( 306_CD ,_, 888_CD cDNA_NN clones_NNS )_)
          (_( Table_NNP 1_CD and_CC Additional_JJ file_NN 1_LS )_) ._. We_PRP chose_VBD contigs_NNS
          consisting_VBG of_IN at_IN least_JJS 5_CD EST_NNP clones_NNS and_CC present_JJ in_IN at_IN
          least_JJS 3_CD IL-_NNP 8_CD libraries_NNS ._. The_DT frequency_NN of_IN occurrence_NN (_( 
          F_NN )_) and_CC Z-_NNP score_NN for_IN all_PDT the_DT contigs_NNS
          in_IN these_DT cDNA_NN libraries_NNS were_VBD calculated_VBN as_IN :_:
          
          
          where_WRB 
          N_NNP 
          IL_NNP 8_CD is_VBZ the_DT number_NN of_IN EST_NNP clones_NNS in_IN
          IL-_NNP 8_CD tissue_NN for_IN a_DT particular_JJ contig_NN ,_, 
          N_NNP 
          total_NN is_VBZ the_DT total_JJ EST_NNP clone_NN count_NN in_IN
          that_DT contig_NN ._. Contigs_NNP were_VBD collected_VBN into_IN groups_NNS based_VBN on_IN
          contig_NN size_NN (_( number_NN of_IN EST_NNP clones_NNS in_IN a_DT contig_NN )_) ,_, and_CC small_JJ
          contig_NN groups_NNS (_( <_NN 1000_CD contigs_NNS )_) were_VBD merged_VBN together_RB
          with_IN neighboring_VBG groups_NNS (_( similar_JJ in_IN contig_NN size_NN )_) to_TO make_VB
          sure_JJ that_IN there_EX were_VBD at_IN least_JJS 1000_CD contigs_NNS in_IN each_DT group_NN ._.
          The_DT rational_JJ for_IN grouping_VBG contigs_NNS based_VBN on_IN size_NN is_VBZ that_IN
          the_DT distribution_NN pattern_NN of_IN 
          F_NN (_( i_NNP ._. e_SYM ._. mean_VB and_CC Z-_NNP score_NN )_) may_MD vary_VB
          for_IN contigs_NNS of_IN different_JJ size_NN ._. 
          n_NN is_VBZ the_DT total_JJ number_NN of_IN contigs_NNS in_IN
          a_DT contig_NN group_NN ,_, Σ_NN 
          F_NN is_VBZ the_DT sum_NN of_IN 
          F_NN in_IN a_DT contig_NN group_NN ,_, and_CC 
          SDV_NNP is_VBZ the_DT standard_JJ deviation_NN of_IN 
          F_NN in_IN a_DT contig_NN group_NN ._. Assuming_VBG a_DT
          Gaussian_NNP Distribution_NN ,_, the_DT fractions_NNS of_IN the_DT population_NN
          that_WDT are_VBP greater_JJR than_IN Z-_NNP score_NN 
          SDV_NNP and_CC also_RB above_IN the_DT mean_NN are_VBP
          15_CD ._. 87_CD %_NN ,_, 2_CD ._. 28_CD %_NN ,_, and_CC 0_CD ._. 13_CD %_NN for_IN Z-_NNP scores_NNS of_IN 1_CD ,_, 2_CD ,_, and_CC 3_CD
          respectively_RB ._. Similarly_RB ,_, a_DT set_NN of_IN tumor_NN cDNA_NN libraries_NNS
          (_( based_VBN on_IN their_PRP$ GenBank_NNP Annotations_NNP )_) in_IN which_WDT IL-_NNP 8_CD is_VBZ
          represented_VBN was_VBD generated_VBN ._. This_DT set_NN of_IN libraries_NNS is_VBZ
          referred_VBN to_TO as_IN IL-_NNP 8_CD -_: tumor_NN tissue_NN ,_, consisting_VBG of_IN 16_CD cDNA_NN
          libraries_NNS (_( 171_CD ,_, 521_CD cDNA_NN clones_NNS )_) (_( Table_NNP 1_CD and_CC Additional_JJ
          file_NN 1_LS )_) ._. Using_VBG the_DT method_NN described_VBD above_IN ,_, a_DT database_NN for_IN
          IL-_NNP 8_CD -_: tumor_NN candidate_NN genes_NNS (_( using_VBG IL-_NNP 8_CD -_: tumor_NN tissue_NN )_) was_VBD
          generated_VBN and_CC IL-_NNP 8_CD -_: tumor_NN Z-_NNP scores_NNS were_VBD calculated_VBN ._.
          Databases_NNP for_IN GRO-α_NNP and_CC GRO-β_NNP related_VBD genes_NNS were_VBD
          generated_VBN in_IN a_DT similar_JJ way_NN using_VBG the_DT cDNA_NN libraries_NNS where_WRB
          GRO-α_NNP or_CC GRO-β_NNP were_VBD represented_VBN respectively_RB (_( Table_NNP
          1_LS )_) ._.
        
      
      
        Authors_NNP '_'' contributions_NNS
        LB_NNP and_CC LUW_NNP carried_VBD out_RP the_DT in_IN silico_NN expression_NN analysis_NN
        and_CC drafted_VBD the_DT manuscript_NN ._. SL_NNP participated_VBD in_IN the_DT
        cataloging_VBG of_IN tumor_NN EST_NNP libraries_NNS ._. LYW_NNP ,_, RB_NNP ,_, JG_NNP ,_, JH_NNP ,_, PQ_NNP ,_, EG_NNP ,_,
        ML_NNP ,_, and_CC MK_NNP participated_VBD in_IN design_NN of_IN the_DT study_NN ._. All_DT authors_NNS
        read_VBP and_CC approved_VBD the_DT final_JJ manuscript_NN ._.
      
    
  
